Medicare Advantage is an $84 billion boondoggle, and one of the simplest, most obvious examples of “waste, fraud and abuse” in the federal government. (That’s not me talking, by the way. That’s the independent Medicare Payment Advisory Commission,

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

The order is based on a "most favored nation" pricing model, which is similar to a policy Trump pushed in his first administration.

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies incorporating drugs payable under Medicare Part B into the program for the first time and is soliciting comments on how to facilitate access to any negotiated maximum fair price for Part B drugs.

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public comments due by June 26.

The Social Security and Medicare Fair Share Act proposes targeting payroll tax loopholes for high-income earners.

Learn about the benefits that become permanent features of Medicare in 2026 and how they have been changed or updated since their inception.